03Jul
Committed to Clarity: FDA’s Dedication to Transparency with the End of ASR
On June 21, the Food and Drug Administration (FDA) released a report titled “Statement on agency’s efforts to increase transparency in medical device reporting.” This report describes updates to FDA’s Medical Device Reporting (MDR) Program, namely...
By:
Morrison & Foerster LLP
Related
The DE OFCCP Week in Review (WIR) is a simple, fast and direct summary of relevant happenings in the...
Read More >
February 13, 2020 was the effective date (the “Effective Date”) for final regulations issued by th...
Read More >
Investment Company Institute conducted a study that shows that 56% of Defined Contribution plan part...
Read More >
In the field of labor relations, there exist some rare occurrences, things that happen so seldom tha...
Read More >
For further information, please visit the White & Case Coronavirus Resource Center. The Federal Trad...
Read More >
On September 18, 2019, the U.S. District Court for the Southern District of New York granted a defen...
Read More >